Click to go to the English version of the site"
Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"
Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
|
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
|
Эко-Вектор (Россия)
Eco-Vector (Russia)
|
Ulrichsweb (Ulrich’s Periodicals Director
|
DUODENAL ULCER
DOI: https://doi.org/10.29296/25879979-2019-07-07
Issue:
7
Year:
2019
The paper highlights the etiology, classification, pathogenesis, and clinical symptoms of duodenal ulcer, and approaches to its diagnosis and effective complex therapy.
Keywords:
duodenal ulcer
bleeding
defense mechanisms
aggression factors
proton pump inhibitors
Helicobacter pylori
References:
- Malfertheiner P., Megraud F., O’Morain C. et al. Management of Helicobacter pylori infection– the Maastricht V/Florence Consensus. Report. Gut. 2017; 66 (1): 6–30.
- Fallone C.A., Chiba N., van Zanten S.V. et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016; 151 (1): 51–69.
- Graham D., Laine L., Toronto H. pylori Consensus Recommendations in Context. Gastroenterology. 2016; 151 (1): 9–12.
- Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am. J. Gastroenterol. 2017; 112 (2): 212–39.
- Sugano K., Tack J., Kuipers E.J. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015; 64: 1353–67.
- Stanghellini V., Chan F., Hasler W.L. et al. Gastroduo denal disorders. Gastroenterology. 2016; 150: 1380–92.
- Moayyedi P., Lacy B.E., Andrews S.N. et al. American College of Gastroenterology and Canadian Association of Gastroenterology guidelines on the management of dyspepsia. Am. J. Gastroenterol. 2017; 112: 988–1013.
- Pimanov S.I., Makarenko E.V. Diagnostika i lechenie infektsii Helicobacter pylori: polozhenija Maastriht V Florentijskogo konsensusa i kommentarii: posobie dlja vrachej. Minsk: Chetyre chetverti, 2017; 90.
- Cheng Y.-J., Nie X.-Y., Chen X.-M. The Role of Macrolide Antibiotics in Increasing Cardio vascular Risk. J. Am. Coll Cardiol. 2015; 66: 2173–84.
- Pimanov S.I., Silivonchik N.N. Funktsional'nye zheludochno-kishechnye rasstrojstva: Rimskij IV konsensus: posobie dlja vrachej. Vitebsk: VGMU, 2016; 190.
- Pimanov S.I., Makarenko E.V. Rekomendatsii Maastriht V Florentijskogo konsensusa po lecheniju helikobakternoj infektsii. Consilium Medicum. 2017: 19–27 (8.1. Gastroenterologija).
- Makarenka A.V., Pimanov S.I. Eradicftion Rate After Randomized Treatment in a Population with High Prevalence of Helicobacter pylori Infection. Helicobacter. 2005; 10: 535.
- Topchij N.V., Toporkov A.S. Primenenie Omitoksa v lechenii erozivno-jazvennyh porazhenij zheludka i dvenadtsatiperstnoj kishki. RMZh. 2011; 12: 748–52.
- Topchij N.V., Devjataeva Ju.M. Optimizatsija priema Omitoksa pri dispepsii. RMZh. 2012; 11: 542–8.
- Minushkin O.N., Zverkov I.V., Barkalova Ju.B. Opyt provedenija eradikatsionnogo lechenija (posledovatel'naja shema) jazvennoj bolezni dvenadtsatiperstnoj kishki. Meditsinskij alfavit. 2016; 34 (297): 50–2.
- Wang Z.H., Gao Q.Y., Fang J.Y. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J. Clin. Gastroenterol. 2013; 47: 25–32.
- Pimanov S.I., Makarenko E.V., Dikareva E.A. Sobljudenie shemy terapii ingibitorami protonnogo nasosa pri postojannom prieme nesteroidnyh protivovospalitel'nyh sredstv. Terapevt. arh. 2015; 87 (4): 58–61.
- Maev I.V., Andreev D.N., Dicheva D.E., Goncharenko A.Ju. Farmakoterapevticheskie aspekty primenenija ingibitorov protonnoj pompy. Meditsinskij vestnik MVD. 2013; 3 (64): 9–14.
- [Maev I.V., Andreev D.N., Dicheva D.E., Goncharenko A. Ju. Farmakoterapevticheskie aspekty primenenija ingibitorov protonnoj pompy. Medicinskij vestnik MVD. 2013; 3 (64): 9–14 (in Russian)]
- Maev I.V., Andreev D.N., Goncharenko A.Ju., Dicheva D.T. Ingibitory protonnoj pompy kak osnova lechenija kislotozavisimyh zabolevanij. Sprav. poliklin. vracha. 2013; 7–8: 42–4.
- [Maev I.V., Andreev D.N., Goncharenko A.Ju., Dicheva D.T. Ingibitory protonnoj pompy kak osnova lechenija kislotozavisimyh zabolevanij. Sprav. poliklin. vracha. 2013; 7–8: 42–4 (in Russian)]
- Bljume H., Donat F., Varnke A., Shug B.S. Farmakokineticheskie lekarstvennye vzaimodejstvija s uchastiem ingibitorov protonnoj pompy. RMZh. 2009; 9: 622.
- [Bljume H., Donat F., Varnke A., Shug B.S. Farmakokineticheskie lekarstvennye vzaimodejstvija s uchastiem ingibitorov protonnoj pompy. RMZh. 2009; 9: 622 (in Russian)]
- Samsonov A.A. Ingibitory protonnoj pompy – preparaty vybora v lechenii kislotozavisimyh zabolevanij. Farmateka. 2007; 6: 10–5.
- [Samsonov A.A. Ingibitory protonnoj pompy – preparaty vybora v lechenii kislotozavisimyh zabolevanij. Farmateka. 2007; 6: 10–5 (in Russian)]